The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis.
Mikhail FominykhVasily ShuvaevIrina MartynkevichLyubov PolushkinaVera UdalevaKudrat AbdulkadyrovPublished in: British journal of haematology (2016)